Organization Profile

You just read:

Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD Following Successful Meeting with FDA

News provided by

Aeterna Zentaris Inc.

Apr 13, 2015, 07:30 ET